Results 111 to 120 of about 5,623,587 (226)
Changing paradigm in the scientific publication process: Are we encouraging Science or Pseudoscience? Urgent need for introspection and self regulation. [PDF]
Nair V.
europepmc +1 more source
Nanosecond infrared laser (NIRL) low‐volume sampling combined with shotgun lipidomics uncovers distinct lipidome alterations in oropharyngeal squamous cell carcinoma (OPSCC) of the palatine tonsil. Several lipid species consistently differentiate tumor from healthy tissue, highlighting their potential as diagnostic markers.
Leonard Kerkhoff +11 more
wiley +1 more source
Patients, patience, and the publication process. [PDF]
Schekman R.
europepmc +1 more source
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala +15 more
wiley +1 more source
Patient partner engagement in the publication process: challenges and possible solutions. [PDF]
Cooksey KE +7 more
europepmc +1 more source
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon +9 more
wiley +1 more source
Reflections on the “Ethics Guideline for using Generative Artificial Intelligence in Scientific Research and Publication Process of Higher Education Institutions” [PDF]
Ekmekçi PE.
europepmc +1 more source
The Journey of Publication Process of The Eurasian Journal of Medicine: From a Local University Journal Promoting to Emerging Sources Citation Indexed (ESCI). [PDF]
Atamanalp SS +3 more
europepmc +1 more source
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee +8 more
wiley +1 more source
Network-based statistics for a community driven transparent publication process. [PDF]
Zimmermann J +7 more
europepmc +1 more source

